24.62
price up icon0.16%   +0.04
after-market  Dopo l'orario di chiusura:  24.65  0.03   +0.12%
loading

Aerovate Therapeutics Inc Borsa (AVTE) Ultime notizie

Insider Selling: Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells 15,000 Shares of Stock - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics CTO sells $265,000 in stock By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Aerovate Therapeutics CFO sells shares worth over $375,000 By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Aerovate Therapeutics (NASDAQ:AVTE) Trading Up 3.6% - MarketBeat

pulisher
MarketBeat

Great Point Partners LLC Decreases Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Shares Down 2% - MarketBeat

pulisher
MarketBeat

Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market (NASDAQ:AVTE) - Seeking Alpha

pulisher
Seeking Alpha

Aerovate Therapeutics files for $350M mixed securities shelf (NASDAQ:AVTE) - Seeking Alpha

pulisher
Seeking Alpha

Vestal Point Capital LP Makes New $9.05 Million Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Given Outperform Rating at Wedbush - Defense World

pulisher
Defense World

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 6.8% - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics' (AVTE) "Outperform" Rating Reiterated at Wedbush - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 6.8% - MarketBeat

pulisher
MarketBeat

Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation - Yahoo Finance UK

pulisher
Yahoo Finance UK

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 6.8% - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Trading 10.9% Higher - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Trading 10.9% Higher - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 16.5% in May - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 5.6% - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 5.6% - MarketBeat

pulisher
MarketBeat

(AVTE) Investment Report - Stock Traders Daily

pulisher
Stock Traders Daily

Balance Sheet Breakdown: Aerovate Therapeutics Inc (AVTE)'s Debt-to-Equity and Long-Term Debt/Eq Ratios ... - The Dwinnex

pulisher
The Dwinnex

Aerovate Therapeutics Inc (AVTE) shows promising results – US Post News - US Post News

pulisher
US Post News

AV-101 trial participants have significant disease at study's start - Pulmonary Hypertension News

pulisher
Pulmonary Hypertension News

AV-101 trial participants have significant disease at study's start - Pulmonary Hypertension News

pulisher
Pulmonary Hypertension News

Here's Why We're Watching Aerovate Therapeutics' (NASDAQ:AVTE) Cash Burn Situation - Simply Wall St

pulisher
Simply Wall St

Aerovate Therapeutics (NASDAQ:AVTE) Given Outperform Rating at Wedbush - Defense World

pulisher
Defense World

Monte Rosa Therapeutics' (GLUE) “Outperform” Rating Reaffirmed at Wedbush - Defense World

pulisher
Defense World

Aerovate Therapeutics' (AVTE) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics' (AVTE) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat

pulisher
MarketBeat

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American ... - GlobeNewswire

pulisher
GlobeNewswire

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

pulisher
GlobeNewswire Inc.

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American ... - Yahoo Finance

pulisher
Yahoo Finance

Principal Securities Inc. Purchases Shares of 6898 Invesco S&P 500 Equal Weight Communication Services ETF ... - Defense World

pulisher
Defense World

Celcuity's (CELC) “Buy” Rating Reaffirmed at Stifel Nicolaus - Defense World

pulisher
Defense World

Viant Technology Inc. (NASDAQ:DSP) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

pulisher
Defense World

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.07 - Defense World

pulisher
Defense World

Boston Partners Makes New $615000 Investment in TDCX Inc. (NYSE:TDCX) - Defense World

pulisher
Defense World

Pixelworks (NASDAQ:PXLW) PT Lowered to $2.00 - Defense World

pulisher
Defense World

10000 Shares in Van Eck Merk Gold Trust (NYSEARCA:OUNZ) Bought by Principal Securities Inc. - Defense World

pulisher
Defense World

Muthusamy Shanmugam Sells 5836 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - Defense World

pulisher
Defense World

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) CEO Timothy P. Noyes Sells 10000 Shares - Defense World

pulisher
Defense World

Jacksam (NASDAQ:JKSM) Releases Quarterly Earnings Results - Defense World

pulisher
Defense World

BNP Paribas Financial Markets Takes $6.54 Million Position in Invesco S&P 500 Equal Weight Technology ETF ... - Defense World

pulisher
Defense World

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells $84320.00 in Stock - Defense World

pulisher
Defense World

Avantax Advisory Services Inc. Increases Holdings in Capital Group International Focus Equity ETF (NYSEARCA:CGXU) - Defense World

pulisher
Defense World

Fortuna Silver Mines Inc. (TSE:FVI) Senior Officer Sells C$94389.30 in Stock - Defense World

pulisher
Defense World

Flutter Entertainment (NYSE:FLUT) Price Target Raised to $245.00 - Defense World

pulisher
Defense World

Jerry L. Peters Sells 10000 Shares of Summit Midstream Partners, LP (NYSE:SMLP) Stock - Defense World

pulisher
Defense World

Aerovate Therapeutics (NASDAQ:AVTE) Trading Down 5.4% After Insider Selling - Defense World

pulisher
Defense World
$83.51
price down icon 0.87%
$26.19
price down icon 0.83%
$162.58
price down icon 2.28%
$160.39
price up icon 0.21%
$92.08
price down icon 4.08%
$387.00
price down icon 0.35%
Capitalizzazione:     |  Volume (24 ore):